Age, Sex, and Initial Diagnosis Shape Mental Disorder Trajectories

Navigating the Evolving Landscape of Mental Disorder Diagnoses

Mental disorders impose a substantial global health burden, significantly contributing to years lived with disability across all ages and sexes [1, 2, 3]. While specific diagnoses like major depressive disorder and anxiety-related disorders are extensively studied for their prevalence and impact [4], clinical experience frequently reveals patients experiencing multiple disease episodes and shifts in diagnosis over time [5]. This diagnostic fluidity, particularly pronounced in adolescents where psychopathology can manifest as a complex system of co-occurring and evolving subclinical symptoms, complicates effective treatment planning and long-term follow-up strategies [6]. Recognizing this challenge, a transdiagnostic perspective, which considers common underlying mechanisms and patterns across different diagnostic categories rather than focusing solely on individual diagnoses, is increasingly vital. However, comprehensive investigations into the heterogeneity of disease development beyond simple comorbidity pairs have been limited [5]. A recent large-scale cohort study now provides detailed insights into these complex patterns of mental disorder progression, offering crucial data for clinicians.

A Comprehensive Look at Disease Progression

To systematically investigate the complexities of mental disorder trajectories, researchers undertook a large-scale cohort study, an observational design that follows a defined group of individuals over time to observe disease development and outcomes. This particular study leveraged comprehensive data from national Danish registers, which provide a unique, population-level dataset of healthcare interactions, ensuring high completeness and minimal selection bias. The investigation included all adult individuals residing in Denmark between 2000 and 2018 who received a first-time diagnosis from one of seven major mental disorder categories: substance use disorder, schizophrenia, psychotic disorder other than schizophrenia, mania and bipolar disorder, major depressive disorder, anxiety-related disorders, or personality disorders.

For each of these seven mental disorder categories, the researchers meticulously calculated age- and sex-specific estimates across four key outcomes. These included (1) the number of diagnostic shifts, which quantifies changes in a patient's primary psychiatric diagnosis over time, reflecting the dynamic nature of mental illness; (2) the absolute risk of pairwise diagnostic shifts, precisely measuring the likelihood of transitioning from one specific diagnosis to another, for example, from major depressive disorder to an anxiety-related disorder; (3) the absolute risk of diagnostic recurrence, which assesses the probability of a patient returning to their initial diagnosis after a period of remission or a different diagnosis; and (4) the number of psychiatric contacts, a broad measure of healthcare utilization encompassing inpatient admissions, outpatient treatment courses, and emergency department visits. The analysis meticulously stratified these outcomes by age, using groups of 18 to 24 years, 25 to 39 years, 40 to 59 years, and 60 years or older, and by male and female sex, allowing for granular insights into demographic influences.

The extensive scope of this study encompassed a total of 273,400 individuals with mental disorders. The mean age at first psychiatric contact for this substantial cohort was 41.4 (18.7) years, with 150,349 individuals (55.0%) being female. These individuals were followed for an impressive 2.1 million person-years, providing a robust and long-term dataset essential for analyzing the intricate patterns of disease progression and healthcare engagement across the lifespan.

Patterns of Diagnostic Change and Healthcare Engagement

Analysis of the extensive follow-up data from the Danish registers unveiled significant and clinically relevant patterns in diagnostic evolution and healthcare utilization among individuals with mental disorders. Overall, the study found that diagnostic shifts, meaning a change in primary psychiatric diagnosis, were observed among 66,474 individuals, representing 24.3% of the total cohort of 273,400 individuals. This substantial proportion indicates that nearly one-quarter of patients experienced a re-evaluation and change in their primary psychiatric diagnosis after initial contact, underscoring the dynamic nature of mental illness and the need for ongoing diagnostic assessment in clinical practice. Furthermore, this diagnostic fluidity was not limited to a single shift; 30,558 individuals (11.8%) experienced multiple diagnostic shifts over the study period, highlighting the complex and often evolving nature of mental disorder trajectories that clinicians must navigate.

The researchers also identified specific diagnostic categories associated with higher rates of both diagnostic change and healthcare engagement. Notably, individuals initially diagnosed with psychotic disorders exhibited the highest number of psychiatric contacts and diagnostic shifts when compared to those with other mental disorder categories. This finding is particularly important for clinicians, as it suggests that patients presenting with psychotic disorders may require more intensive and adaptive long-term management strategies, given their greater propensity for diagnostic re-evaluation and their higher utilization of inpatient admissions, outpatient treatment courses, and emergency department visits. This increased healthcare burden and diagnostic instability point to a need for robust, flexible care pathways for this patient group.

Age and Sex as Key Determinants of Disease Trajectory

Moving beyond the initial diagnosis, the study compellingly demonstrated that a patient's age and sex are critical determinants shaping the long-term course of mental disorders. The researchers observed that younger age at first psychiatric contact was consistently associated with a greater number of psychiatric contacts, a finding that held true irrespective of the specific diagnosis given at that initial presentation. This pattern of increased healthcare utilization in younger patients suggests a more intensive and potentially complex clinical journey. Furthermore, this vulnerability extended to diagnostic stability, as younger age at first contact also correlated with a higher number of diagnostic shifts, again regardless of the initial diagnosis. A younger age at first contact also predicted higher probabilities for most pairwise diagnostic shifts between different disorder categories and a higher probability for diagnostic recurrence, collectively indicating a more dynamic and less stable disease trajectory for younger patients. For clinicians, this highlights younger patients as a particularly high-risk group requiring proactive monitoring and flexible treatment approaches.

Sex-specific patterns in diagnostic shifts were also clearly delineated, offering valuable insights for tailored clinical vigilance. Males demonstrated a distinct propensity for certain diagnostic transitions, showing a higher absolute risk of diagnostic shifts to substance use disorders compared to females. Similarly, males exhibited a higher absolute risk of diagnostic shifts to schizophrenia spectrum disorders than their female counterparts. Conversely, females displayed a different pattern of diagnostic evolution, with a higher probability of diagnostic shifts to mood disorders, a higher probability of diagnostic shifts to anxiety-related disorders, and a higher probability of diagnostic shifts to personality disorders when compared to males. These sex-specific findings underscore the importance of considering sex-linked biological, psychological, and social factors that may influence disease progression and diagnostic evolution, informing targeted screening and preventive strategies for both male and female patients.

Clinical Implications for Personalized Care

The comprehensive investigation into sex and age patterns of disease development across seven major groups of mental disorders provides direct and actionable clinical implications for managing patients with psychiatric conditions. The study's overarching conclusion firmly establishes that disease development across the four measured outcomes (number of diagnostic shifts, absolute risk of pairwise diagnostic shifts, absolute risk of diagnostic recurrence, and number of psychiatric contacts) was highly dependent on the specific diagnosis given at first contact. This finding underscores the critical importance of initial diagnostic accuracy, while simultaneously emphasizing that an initial diagnosis should be viewed not as a static label, but as a starting point in a potentially evolving clinical trajectory that requires ongoing assessment.

Furthermore, the researchers determined that disease development across these four outcomes was also highly dependent on the patient's sex and age group. These granular insights into how age and sex modulate disease progression, diagnostic stability, and healthcare utilization are crucial for refining clinical practice. Specifically, these findings are vital for treatment planning and follow-up strategies, enabling clinicians to anticipate potential diagnostic shifts or recurrences based on a patient's demographic profile and initial presentation. By understanding these predictable patterns, healthcare providers can tailor interventions more effectively, moving towards a more personalized and anticipatory approach to psychiatric care.

The ability to identify specific risk factors for particular disease trajectories also means these findings are important to ensure that preventive initiatives are offered to high-risk individuals. For example, a younger male presenting with an initial diagnosis might be identified as having a higher absolute risk for future shifts to substance use disorders or schizophrenia spectrum disorders, prompting earlier, targeted preventive interventions such as substance abuse screening or psychoeducation on early psychosis symptoms. Conversely, a female patient might be monitored more closely for shifts to mood disorders, anxiety-related disorders, or personality disorders, potentially through enhanced screening for these conditions. This proactive approach, informed by the study's detailed age- and sex-specific estimates, can lead to earlier detection, more timely interventions, and ultimately, improved long-term outcomes for patients navigating complex mental disorder trajectories.

References

1. James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2018. doi:10.1016/s0140-6736(18)32279-7

2. Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020. doi:10.1016/s0140-6736(20)30925-9

3. Ferrari AJ, Santomauro D, Aali A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024. doi:10.1016/s0140-6736(24)00757-8

4. Santomauro D, Herrera AMM, Shadid J, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 2021. doi:10.1016/s0140-6736(21)02143-7

5. Fusar-Poli P, Solmi M, Brondino N, et al. Transdiagnostic psychiatry: a systematic review. World Psychiatry. 2019. doi:10.1002/wps.20631

6. Hirsig A, Häfeli XA, Schmidt SJ. Efficacy of a transdiagnostic Internet prevention approach in adolescents (EMPATIA study): study protocol of a randomized controlled trial. Trials. 2024. doi:10.1186/s13063-024-08241-3